Skip to main content
Fig. 1 | Acta Neuropathologica Communications

Fig. 1

From: Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases

Fig. 1

CSF AD Biomarkers according to AD Neuropathologic Scores. (A) CSF Aβ42 levels compared between patients grouped by AD neuropathologic scores at autopsy. (B) CSF p-tau181 levels compared between patients grouped by AD neuropathologic scores at autopsy. (C) CSF t-tau levels compared between patients grouped by AD neuropathologic scores at autopsy. Note Horizontal lines represent pre-determined cut-off values

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us